"ACHTUNG: Aktuelle Informationen zu unserer Erreichbarkeit während der Corona-Krise finden Sie tagesaktuell auf der Startseite unserer Website!"

During the past decade, Klinik und Poliklinik für Neurologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinik und Poliklinik für Neurologie" #1 sponsor was "University Hospital Heidelberg" with 2 trials, followed by "Celldex Therapeutics" with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored, "Isarna Therapeutics GmbH" with 1 trials sponsored and "Prof. Dr. Berthold Schalke" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinik und Poliklinik für Neurologie" #1 collaborator was "Crolll Gmbh" with 1 trials as a collaborator, "Essex Pharma Germany" with 1 trials as a collaborator, "Essex Pharma GmbH" with 1 trials as a collaborator, "German Cancer Aid" with 1 trials as a collaborator and "German Cancer Research Center" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Klinik und Poliklinik für Neurologie" are "Glioblastoma" (4 trials), "Anaplastic Astrocytoma" (1 trials), "Giant Cell Glioblastoma" (1 trials), "Glioblastoma With Oligodendroglial Component" (1 trials) and "Glioblastoma, Adult" (1 trials). Many other conditions were trialed in "Klinik und Poliklinik für Neurologie" in a lesser frequency.

Most popular intervention types in "Klinik und Poliklinik für Neurologie" are "Drug" (7 trials), "Device" (1 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "APG101" (1 trials), "Alectinib" (1 trials), "Atezolizumab" (1 trials), "CETEG" (1 trials) and "Data Collection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinik und Poliklinik für Neurologie" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Klinik und Poliklinik für Neurologie". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Klinik und Poliklinik für Neurologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Klinik und Poliklinik für Neurologie, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".